Skip to main content

Ocular Microbiome clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Azithromycin for Meibomian Gland Disease

    open to eligible people ages 18 years and up

    This study aims to elucidate the effectiveness of oral azithromycin in treating symptomatic dry eye syndrome secondary to Meibomian gland dysfunction.

    San Francisco, California

Last updated: